RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Boston, MA · +49 more sites
5 recruiting psoriasis studies with a site in Boston, MA.
Sponsor: National Cancer Institute (NCI)
Boston, MA · +49 more sites
Sponsor: Oruka Therapeutics, Inc.
Boston, MA · +21 more sites
Sponsor: UCB Biopharma SRL
Boston, MA · +5 more sites
Sponsor: Duke University
Boston, MA · +72 more sites
Sponsor: NYU Langone Health
Boston, MA · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.